Vanda Pharmaceuticals (VNDA) Tax Rate (2010 - 2026)
Vanda Pharmaceuticals (VNDA) reported Tax Rate of 0.21% for Q1 2026, down 2128.0% on a YoY basis from 0.01% in Q1 2025, and up 99.92% sequentially from 271.53% in Q4 2025.
Vanda Pharmaceuticals (VNDA) Tax Rate (2010 - 2026) Analysis & Trends
Vanda Pharmaceuticals (VNDA) has 12 years of Tax Rate data on file, last reported at 0.21% in Q1 2026.
- For the quarter ending Q1 2026, Tax Rate fell 2128.0% year-over-year to 0.21%; the trailing twelve-month figure through Mar 2026 stood at 59.98% (down 8046.0% YoY), and the FY2025 full-year result was 59.02%, down 7656.0% from the prior year.
- Tax Rate grew to 0.21% in Q1 2026, from 271.53% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 214.17% in Q3 2023 to a low of 271.53% in Q4 2025.
- A 5-year average of 13.52% and a median of 21.07% in 2025 frame the typical range for Tax Rate.
- Across the five-year window, Tax Rate surged 17388 bps in 2023 and tumbled 29648 bps in 2025, its largest moves.
- Tracing VNDA's Tax Rate over 5 years: stood at 28.63% in 2022, then sank by 254 bps to 43.95% in 2023, then soared by 157 bps to 24.95% in 2024, then plunged by 1188 bps to 271.53% in 2025, then soared by 100 bps to 0.21% in 2026.
- Business Quant data shows VNDA's Tax Rate at 0.21% in Q1 2026, 271.53% in Q4 2025, and 20.43% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.29% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -5.41% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 17.68% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 12.51% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 33.09% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vanda Pharmaceuticals | 318.71 Mn | 116.40 Mn | 48.56 Mn | -0.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.21% |
| Mar 31, 2026 | -0.21% |
| Mar 31, 2026 | -0.21% |
| Dec 31, 2025 | -271.53% |
| Dec 31, 2025 | -271.53% |
| Dec 31, 2025 | -271.53% |
| Sep 30, 2025 | 20.43% |
| Sep 30, 2025 | 20.43% |
| Sep 30, 2025 | 20.43% |
| Jun 30, 2025 | 22.07% |
| Jun 30, 2025 | 22.07% |
| Jun 30, 2025 | 22.07% |
| Mar 31, 2025 | 21.07% |
| Mar 31, 2025 | 21.07% |
| Mar 31, 2025 | 21.07% |
| Dec 31, 2024 | 24.95% |
| Dec 31, 2024 | 24.95% |
| Dec 31, 2024 | 24.95% |
| Sep 30, 2024 | 14.41% |
| Sep 30, 2024 | 14.41% |